| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | Chief Operating Officer | Common Stock | 1,250 | $5,300 | $4.24 | 15 Oct 2025 | Direct |
| Aardvark Therapeutics, Inc. | Chief Operating Officer | Stock option (right to buy) | 40,052 | 15 Oct 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AARD | Aardvark Therapeutics, Inc. | 15 Oct 2025 | 2 | +$5,300 | 4 | Chief Operating Officer | 16 Oct 2025, 18:12 |
| AARD | Aardvark Therapeutics, Inc. | 11 Jun 2025 | 1 | $0 | 4 | Chief Operating Officer | 13 Jun 2025, 16:05 |
| AARD | Aardvark Therapeutics, Inc. | 12 Feb 2025 | 0 | $0 | 3 | Chief Operating Officer | 12 Feb 2025, 19:24 |